# OnCo record cd33-expression (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/cd33-expression/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "cd33-expression" ;
  schema:name "CD33 expression (CD33-positive)"@en ;
  schema:alternateName "CD33-positive"@en, "CD33+"@en, "CD33 expression"@en, "CD33 positive AML"@en ;
  schema:description "CD33 is a myeloid antigen on the blasts of about 90 percent of acute myeloid leukaemias. Gemtuzumab ozogamicin's label requires CD33-positive disease."@en ;
  schema:url <https://onco.cc/biomarkers/cd33-expression/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05> ;
  onco:tag "biomarker", "surface-antigen" ;
  onco:related <https://onco.cc/biomarkers/flt3-itd/>, <https://onco.cc/biomarkers/npm1-mutation/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-paediatric/> ;
  onco:drugs <https://onco.cc/drugs/gemtuzumab-ozogamicin/> ;
  onco:terms <https://onco.cc/terms/flow-cytometry/>, <https://onco.cc/terms/cytogenetics/> .